Discussion
This paper is the first, to our knowledge, to document the lived experience of African women oncologists. Our results show that women oncologists experience challenges at various levels based on individual, workplace and societal factors. However, women oncologists in Africa strongly feel that they have a unique role to play in the health ecosystem and much to contribute to cancer care provision.
Both ASCO and ESMO have identified significant challenges that women oncologists in Europe and America face, which may help explain why women compose only 28.4% of the oncology workforce.7 Many challenges identified by women oncologists in Africa were similar to those previously identified in these studies, but others were unique to this demographic.
The gender wage gap is a familiar and enduring challenge, despite equal-pay legislation in many countries.7 Our cohort from Africa did not report perceptions of pay asymmetries which could be explained by the fact that many of the oncologists in our cohort worked in public facilities with a fixed salary. Anecdotally, the trend might be seen in the public–private sector with women reporting fewer referrals and less monthly earnings. Similarly, 40% of women oncologists in India stated that they do not get equal patient referrals especially early in their careers which can be mitigated by working in a team with a women lead.9
Women are often regarded as less competent than men, despite possessing equivalent experience and qualifications.7 This was felt strongly in the cohort. Behavioural double standards have also been well-documented and must be addressed. Men who strive for leadership positions are praised for their ambition, while women who do so are portrayed as being bossy and rude.10 Furthermore, the focus group discussions revealed that women put pressure on themselves to succeed and rise above societal expectations of incompetence, potentially leading women in medicine to feel pressure to go above and beyond in ways that may manifest as perfectionism.
There is also a dysfunctional pipeline in medicine, in which men and women do not succeed at the same rate.11 This is reflected in medical leadership, which is disproportionately male-dominated.5 Our cohort expressed similar views with interpersonal, institutional and societal barriers hampering their ability to progress academically or in leadership roles.
Testimonials from women oncologists across the USA have identified the ‘womanhood penalty’ as a significant barrier, which suggests that regardless of parity, women are not succeeding at the same rate nor receiving equal compensation compared with their male counterparts.5 12 Study participants felt that this barrier was particularly accentuated in Africa due to the increased socio-cultural and community demands on African women. As this was felt to be the greatest hindrance to personal development, strategies to improve these were noted to be of utmost urgency and included developing childcare facilities, improving maternity leave, enforcing parental leave, and developing flexible working hours.
Mentorship is critical for women’s career success as it can reduce gender inequity by building resilience, teaching negotiation skills, offering opportunities and providing support networks.5 12 There is a paucity of mentors available to guide young women in oncology early in their careers. African women also acknowledge that despite mentoring being essential, they themselves do not have the capacity to meet the demands of mentorship. The task force noted this paucity but suggested expansion by developing international networks and innovative strategies, such as the development of mentorship pods.
Sexual harassment was not identified as a major problem in this study, but it emerged during the discussion that this may be due to a lack of recognition of what sexual harassment entails. Starting in medical school, women in medicine experience more sexual harassment compared with other STEM (Science, Technology, Engineering, Mathematics) disciplines.13 14 Several researchers have highlighted how sexist norms embedded in work environments further perpetuate sexual harassment.15–17 The cultural conditioning of women to normalise and even expect unwanted verbal and physical conduct could explain their lack of identification in the Delphi process. Sexual harassment significantly affects the advancement of women in medicine.18 Education of female and male oncologists to recognise sexual harassment will help identify the problem, estimate its effects and enable the development of culturally relevant solutions.
Regarding solutions at the individual level, women oncologists must develop personal strategies to thrive. Female sex has been identified as a risk factor for burnout in several studies, although this has not been maintained in multivariate analysis.19 20 Practising self-care and taking regular time off will reduce burnout.21 22
At the institutional level, challenges faced by women should be openly recognised and discussed and solutions proffered. Psychosocial support should be provided when needed. Formal protocols in tackling sexual harassment should be available to all persons within the institutions and must be part of orientation processes. Channels for reporting harassment including subtle microaggressions should be opened. Grievances must be investigated and perpetrators punished to serve as a deterrent to others.
Avenues for attaining leadership roles must be outlined and opened to all qualified personnel irrespective of gender. The use of affirmative action or quotas as used in other sectors to improve diversity can be replicated to bolster female leadership. Such high-achieving women will serve as role models for early career women oncologists. Government policies should also reflect a desire for women to thrive in positions of power. Investment in training a robust oncology workforce will mitigate the effect of workload pressures, enabling oncologists to engage in more research and leadership.
Our study revealed that African women oncologists lack access to research training and funding. A recent analysis showed that sub-Saharan African female authors comprised the lowest percentage of authors in a major global oncology journal.23 The global oncology community must support and acknowledge African women oncologists and researchers.
This study has several strengths—most notably, its unique account of the lived experience of African women oncologists. The cohort that was established here will serve as valuable champions for future projects geared towards African women oncologist empowerment and development. However, limitations should be noted. The group was a non-random sample, and thus the opinions expressed may not be generalisable to the broader population of African women oncologists. Further, discussions were only held in English, limiting opportunities for non-English speaking participants. As well, the non-anonymised format of the discussions may have limited opportunities for participants to speak freely about their experiences, particularly for those with existing relationships with fellow participants. However, no discomfort or hesitancy to speak was observed by the moderators of the study.
Despite increases in female representation in oncology, challenges facing women oncologists prevail at every level of the social-ecological model. This multilevel nature suggests a need to intervene with multifaceted, comprehensive interventions. The solutions proposed here offer a hopeful glimpse into the future for African women oncologists.
It is essential to assess the gender gap over time to gauge progress or lack thereof. A recent update of the ESMO women study found that while some progress took place between 2016 and 2021, there is still a substantial gap.24 Future research for African female oncologists should incorporate perspectives from men, quantitative methods such as wider surveys to include more women from across the continent and continuously update the data to take stock of progress and inform gender transformative policies.